PVT1 Mediates Cell Proliferation, Apoptosis and Radioresistance in Nasopharyngeal Carcinoma Through Regulating miR-515-5p/PIK3CA Axis

References

• Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024. doi:10.1016/S0140-6736(15)00055-026321262
   PubMed Web of Science ®Google Scholar
• Qu C, Zhao Y, Feng G, et al. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma. J Cell Mol Med. 2017;21(11):2872–2883. doi:10.1111/jcmm.1320028557284
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yu X, Zhou Z, et al. LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling. Cancer Med. 2019;8(13):6082–6094. doi:10.1002/cam4.250631436393
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159. doi:10.1038/nrg252119188922
   PubMed Web of Science ®Google Scholar
• Song W, Zhang J, Xia Q, Sun M. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Cell Cycle. 2019;18(22):3177–3188. doi:10.1080/15384101.2019.167108931564201
   PubMed Web of Science ®Google Scholar
• Wang B, Zheng J, Li R, et al. Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells. Cell Death Dis. 2019;10(10):764. doi:10.1038/s41419-019-1996-031601781
   PubMedGoogle Scholar
• Hu X, Jiang H, Jiang X. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a. Cancer Biol Ther. 2017;18(5):331–338. doi:10.1080/15384047.2017.131034828402230
   PubMed Web of Science ®Google Scholar
• Li G, Liu Y, Liu C, et al. Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing. BMC Cancer. 2016;16:719. doi:10.1186/s12885-016-2755-627599611
   PubMed Web of Science ®Google Scholar
• He Y, Jing Y, Wei F, et al. Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma. Cell Death Dis. 2018;9(2):235. doi:10.1038/s41419-018-0265-y29445147
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227. doi:10.1146/annurev.pathol.4.110807.09222218817506
   PubMed Web of Science ®Google Scholar
• Huang X, Taeb S, Jahangiri S, et al. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 2013;73(23):6972–6986. doi:10.1158/0008-5472.CAN-13-165724145350
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang J, Zhang L, et al. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology. 2013;145(5):1133–1143.e1112. doi:10.1053/j.gastro.2013.07.04823916944
   PubMed Web of Science ®Google Scholar
• Zhang P, Wang L, Rodriguez-Aguayo C, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014;5:5671. doi:10.1038/ncomms667125476932
   PubMed Web of Science ®Google Scholar
• Qiao K, Ning S, Wan L, et al. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/hippo signaling pathway. J Exp Clin Cancer Res. 2019;38(1):418. doi:10.1186/s13046-019-1421-731623640
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Huang H, Wang Y, Zhang F, Wang S. Hsa_circ_0067997 promotes the progression of gastric cancer by inhibition of miR-515-5p and activation of X chromosome-linked inhibitor of apoptosis (XIAP). Artif Cells Nanomed Biotechnol. 2019;47(1):308–318. doi:10.1080/21691401.2018.155378730688097
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. Int J Biol Macromol. 2019;129:227–232. doi:10.1016/j.ijbiomac.2019.01.12730685303
   PubMed Web of Science ®Google Scholar
• Ma YY, Wei SJ, Lin YC, et al. PIK3CA as an oncogene in cervical cancer. Oncogene. 2000;19(23):2739–2744. doi:10.1038/sj.onc.120359710851074
   PubMed Web of Science ®Google Scholar
• Huang D, Tang L, Yang F, Jin J, Guan X. mutations contribute to fulvestrant resistance in ER-positive breast cancer. Am J Transl Res. 2019;11(9):6055–6065.31632573
   PubMed Web of Science ®Google Scholar
• Fendri A, Khabir A, Mnejja W, et al. PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma. Cancer Sci. 2009;100(11):2034–2039. doi:10.1111/j.1349-7006.2009.01292.x19735264
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–D97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Wang B, Xu L, Zhang J, et al. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Biomed Pharmacother. 2020;129:110268. doi:10.1016/j.biopha.2020.11026832563146
   PubMed Web of Science ®Google Scholar
• Long X, Song K, Hu H, et al. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 2019;38(1):345. doi:10.1186/s13046-019-1329-231391118
   PubMed Web of Science ®Google Scholar
• Tan J, Qiu K, Li M, Liang Y. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett. 2015;589(20 Pt B):3175–3181. doi:10.1016/j.febslet.2015.08.02026318860
   PubMed Web of Science ®Google Scholar
• Sonnenblick A, Venet D, Brohée S, Pondé N, Sotiriou C. pAKT pathway activation is associated with mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. NPJ Breast Cancer. 2019;5:7. doi:10.1038/s41523-019-0102-130729154
   PubMed Web of Science ®Google Scholar
• Tomioka A, Tanaka M, De Velasco MA, et al. Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther. 2008;7(7):1864–1870. doi:10.1158/1535-7163.MCT-07-219818644998
   PubMed Web of Science ®Google Scholar
• Tanno S, Yanagawa N, Habiro A, et al. Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance. Cancer Res. 2004;64(10):3486–3490. doi:10.1158/0008-5472.CAN-03-178815150102
   PubMed Web of Science ®Google Scholar
• Zou Y, Yao S, Chen X, et al. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. Eur J Cell Biol. 2018;97(5):369–378. doi:10.1016/j.ejcb.2018.04.00529773344
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu Y, Liu AM, Feng Y, Chen Y. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185. Eur Rev Med Pharmacol Sci. 2019;23(17):7457–7468. doi:10.26355/eurrev_201909_1885531539133
   PubMed Web of Science ®Google Scholar
• Wang X, Huang Y, Guo R, et al. Clinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinoma. Exp Ther Med. 2017;13(3):1064–1068. doi:10.3892/etm.2017.407628450943
   PubMed Web of Science ®Google Scholar